SCHEMBL4731535

SCHEMBL4731535

O=C1C=C(c2cccs2)CO1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.37
MAPT P10636 3/20 0.37
L3MBTL1 Q9Y468 2/20 0.37
MAPK1 P28482 1/20 0.37
RPS6KB2 Q9UBS0 2/20 0.36
LTK P29376 1/20 0.36
CDK5 Q00535 1/20 0.36
MST1R Q04912 1/20 0.36
DYRK1A Q13627 1/20 0.36
CLK4 Q9HAZ1 1/20 0.36
GALR1 P47211 1/20 0.36
MAOB P27338 1/20 0.35
HPGD P15428 3/20 0.34
MEN1 O00255 2/20 0.34
KMT2A Q03164 2/20 0.34
KDM4E B2RXH2 2/20 0.34
TDP1 Q9NUW8 1/20 0.34
POLB P06746 1/20 0.34
SMN1; SMN2 Q16637 2/20 0.34
F2 P00734 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29080000 0.84 RPS6KB2 (0.38) ALDH1A1MAPTL3MBTL1MAPK1RPS6KB2
SCHEMBL7534042 0.71 ALDH1A1 (0.37) ALDH1A1MAPTL3MBTL1MAPK1RPS6KB2
SCHEMBL9483157 0.69 ALDH1A1 (0.39) ALDH1A1MAPTL3MBTL1MAPK1LTK
SCHEMBL28683146 0.69 RPS6KB2 (0.38) ALDH1A1MAPTL3MBTL1MAPK1RPS6KB2
SCHEMBL979881 0.68 KMT2A (0.45) ALDH1A1MAPTMAOBHPGDMEN1
SCHEMBL5146143 0.67 PGR (0.40) ALDH1A1MAPTL3MBTL1MAPK1LTK
SCHEMBL678890 0.67 NR1I2 (0.39) ALDH1A1MAPTL3MBTL1MAPK1LTK
SCHEMBL22246046 0.67 KMT2A (0.44) ALDH1A1MAPTL3MBTL1RPS6KB2LTK
SCHEMBL4730788 0.67 CYP2A6 (0.36) GALR1MAOBTDP1CA9CA1
SCHEMBL8082831 0.66 KDM4E (0.44) ALDH1A1MAPTL3MBTL1RPS6KB2LTK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-101646664-B Furanone compounds BIOSIGNAL LTD 2013-12-04 CN disclosed
US-8586618-B2 Furanone compounds and lactam analogues thereof BIOSIGNAL LIMITED (AU) 2013-11-19 US disclosed
US-20100035948-A1 Furanone compounds and lactam analogues thereof UNILEVER PLC (GB) 2010-02-11 US disclosed
US-20100035948-A1 Furanone compounds and lactam analogues thereof UNILEVER PLC (GB) 2010-02-11 US disclosed
WO-2008040097-A1 FURANONE COMPOUNDS AND LACTAM ANALOGUES THEREOF BIOSIGNAL LIMITED (AU) 2008-04-10 WO disclosed
WO-2008040097-A1 FURANONE COMPOUNDS AND LACTAM ANALOGUES THEREOF BIOSIGNAL LIMITED (AU) 2008-04-10 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100035948-A1 Furanone compounds and lactam analogues thereof FDPS, CYP2C19, MRPL21 ALDH1A1 1750/4885MAPT 4714/4885L3MBTL1 4867/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.